
About Medford Pharmaceuticals LLP
Data last updated:
Medford Pharmaceuticals LLP is a limited liability partnership (LLP) based in Bangalore, Karnataka, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 December 2018 and has been in existence for over 8 years.
The LLP is registered with the Registrar of Companies (ROC), Bangalore, under LLPIN AAN-8052. Its GSTIN is 29ABKFM3832H1Z0 (Karnataka).
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners including Kongarahalli Ganga Reddy Nagaraja and Geethanjali Chandrareddy.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹4.13 Cr, a growth of 30% compared to the previous year. For the same year it recorded a net profit of ₹14.75 Lakh (net margin 3.6%) and EBITDA of -₹22.68 Lakh (EBITDA margin -5.5%). Revenue has grown at a compounded annual rate (CAGR) of 146% over three years.
The LLP has about 59 employees on its provident fund (EPFO) records.
As per MCA filings, the LLP has open charges of ₹1.4 Cr on record.
Medford Pharmaceuticals LLP is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0272731). For more details, the LLP can be reached via its website medfordpharma.in.
Company details
Recognitions & Rankings of Medford Pharmaceuticals
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-KR-03-0272731
Contact details
Medford Pharmaceuticals LLP's registered office is in Bangalore, Karnataka. Its website is medfordpharma.in. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressNo.201 2nd Floor Unispace Business Centre Adjacent Ginger Hotel Epip Zone Whitef, Ield, Bangalore, Karnataka, India – 560066
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Medford Pharmaceuticals LLP, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Medford Pharmaceuticals LLP
FY 2025 filings availableMedford Pharmaceuticals LLP reported revenue of ₹4.13 Cr (up 30% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 146% over three years, including 30% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | |||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | ₹14.75 Lakh | ||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 3.6% | ||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Medford Pharmaceuticals LLP, buy the company report.
Designated partners of Medford Pharmaceuticals LLP
Medford Pharmaceuticals has 5 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kongarahalli Ganga Reddy Nagaraja | Designated Partner | 19 Dec 2018 | 7 Years 10 Months | Current |
| Geethanjali Chandrareddy Also directs: G S S Pharma Private Limited | Designated Partner | 19 Dec 2018 | 7 Years 10 Months | Current |
| Parthasarathy Hari | Designated Partner | 30 Jan 2025 | 1 Years 9 Months | Current |
| Babukumar Kavitha Also directs: G S S Pharma Private Limited | Designated Partner | 30 Jan 2025 | 1 Years 9 Months | Current |
| Shivanna Hassan Sridhar Also directs: G S S Pharma Private Limited | Designated Partner | 30 Jan 2025 | 1 Years 9 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Apr 2024 | 100922948 | Kotak Mahindra Bank Limited | ₹65 Lakh | Open | |
| 06 Jun 2023 | 100740028 | Idfc First Bank Limited | ₹75 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Medford Pharmaceuticals LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medford Pharmaceuticals LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Medford Pharmaceuticals LLP has a workforce of 59 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 59 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 |
To see the full employee and EPFO history of Medford Pharmaceuticals LLP, buy the company report.
GST
Medford Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29ABKFM3832H1Z0 | Karnataka | Active | 11 Feb 2019 |
To see the full GST registrations and return filing status of Medford Pharmaceuticals LLP, buy the company report.
Recent activity
Medford Pharmaceuticals LLP has 5 designated partner changes on record since 2018: 5 appointments. The latest: Babukumar Kavitha was appointed as Designated Partner on 30 Jan 2025.
Frequently asked questions
Medford Pharmaceuticals is an active limited liability partnership based in Bangalore, Karnataka, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 19 December 2018 (8+ years old) and is registered under LLPIN AAN-8052.
Medford Pharmaceuticals has 5 current designated partners:
- Kongarahalli Ganga Reddy Nagaraja - Designated Partner
- Geethanjali Chandrareddy - Designated Partner
- Parthasarathy Hari - Designated Partner
- Babukumar Kavitha - Designated Partner
- Shivanna Hassan Sridhar - Designated Partner
The latest financial statements of Medford Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Medford Pharmaceuticals is 29ABKFM3832H1Z0, registered in Karnataka.
The LLPIN (Limited Liability Partnership Identification Number) of Medford Pharmaceuticals is AAN-8052. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Medford Pharmaceuticals was incorporated on 19 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Bangalore.
Babukumar Kavitha was appointed as Designated Partner on 30 Jan 2025. Parthasarathy Hari was appointed as Designated Partner on 30 Jan 2025. Shivanna Hassan Sridhar was appointed as Designated Partner on 30 Jan 2025. Medford Pharmaceuticals has 5 designated partner changes on record in total.
Yes, Medford Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Medford Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0272731).
Medford Pharmaceuticals can be reached through the website medfordpharma.in. Its registered office is in Bangalore, Karnataka, India.

